
Mithra Pharmaceuticals S.A.
MITRA | XBRU
Overview
Corporate Details
- ISIN(s):
- BE0974283153 (+1 more)
- LEI:
- 5493002FDD273HTEKK14
- Country:
- Belgium
- Address:
- Rue Saint-Georges 5, 4000 Liège
- Website:
- https://www.mithra.com/en/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
We are committed to providing women new choices improving their daily life For over twenty years, Mithra has dedicated its researches so as to redefine women’s health by bringing innovative products in the fields of contraception and menopause. Today, Mithra counts two complementary platforms: its portfolio of innovative products based on Estetrol (E4) and its portfolio of Complex Therapeutics. The whole supported by the Mithra CDMO, a technological platform offering a wide range of services going from pharmaceutical development to commercial manufacturing. Since the launch of the first generic contraceptive pill in Belgium, Mithra always focused on innovation for women. After years of research and development, our pipeline today includes late-stage development products, potential blockbusters and complex therapeutics in the fields of contraception and menopause. These projects are powered by our Mithra CDMO, our unique R&D and manufacturing platform.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2024-06-11 10:00 |
Regulatory News Service
2024-06-11_Mithra_Press-Release_Mithra sells to GR_EN-FS (003) (002)-PDF.pdf
|
English | 179.8 KB | |
2024-06-11 10:00 |
Regulatory News Service
2024-06-11_Mithra_Press-Release_Mithra sells to GR_FR-FS-PDF.pdf
|
French | 126.7 KB | |
2024-06-10 19:15 |
Regulatory News Service
2024-06-10_Mithra_Press-Release_Mithra files for bankruptcy AND sells to GR_EN.…
|
English | 181.9 KB | |
2024-06-10 19:15 |
Regulatory News Service
2024-06-10_Mithra_Press-Release_Mithra files for bankruptcy AND sells to GR_FR.…
|
French | 128.7 KB | |
2024-06-04 08:00 |
Regulatory News Service
2024-0~1.PDF
|
English | 153.0 KB | |
2024-06-04 08:00 |
Regulatory News Service
2024-0~2.PDF
|
French | 158.7 KB | |
2024-05-28 15:00 |
Inside Information Statement
2024-05-28_Mithra_Press-release_Mithra postpones its annual general meeting_EN.…
|
English | 139.6 KB | |
2024-05-28 15:00 |
General Meeting Notice
2024-05-28_Mithra_Press-release_Mithra postpones its annual general meeting_FR.…
|
French | 143.3 KB | |
2024-05-10 16:30 |
Regulatory News Service
2024-05-10_Mithra_Press-release_Additional patent protection NEXSTELLIS_EN.pdf
|
English | 124.3 KB | |
2024-05-10 16:30 |
Regulatory News Service
2024-05-10_Mithra_Press-release_Additional patent protection NEXSTELLIS_FR.pdf
|
French | 126.5 KB | |
2024-05-03 17:30 |
Takeover Announcement Report
2024-05-03_Mithra_Press-release_Mithra Announces Exclusive Negotiations and Fun…
|
English | 142.7 KB | |
2024-05-03 17:30 |
Regulatory News Service
2024-05-03_Mithra_Press-release_Mithra Announces Exclusive Negotiations and Fun…
|
French | 145.9 KB | |
2024-04-30 10:30 |
Declaration of Voting Results & Voting Rights Announcements
2024-04-30_MITHRA_VOTING-BY-MAIL-FORM_AGO-MAY-2024_EN.pdf
|
English | 141.0 KB | |
2024-04-30 10:30 |
Regulatory News Service
2024-04-30_MITHRA_AGENDA_AGO-MAY-2024_FR.pdf
|
French | 143.1 KB | |
2024-04-30 10:30 |
Proxy Solicitation & Information Statements
2024-04-30_MITHRA_PROXY-FORM_AGO-MAY-2024_EN.pdf
|
English | 145.2 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
2023-01-17 | NOSHAQ SA | Board | Other | 172,574 | 617,814.92 EUR |
2022-11-17 | NOSHAQ SA | Board | Other | 172,574 | 1,052,701.40 EUR |
2022-07-18 | NOSHAQ SA | Board | Other | 156,250 | 1,006,250.00 EUR |
2022-05-13 | NOSHAQ SA | Board | Other | 156,250 | 1,239,062.50 EUR |
2022-04-13 | Gordenne Valérie | Other | Sell | 8,500 | 87,380.00 EUR |
2022-03-29 | Fornieri Francesco | Board | Sell | 100,000 | 1,312,000.00 EUR |
2022-03-25 | Fornieri Francesco | Board | Sell | 35,893 | 486,530.57 EUR |
2022-03-24 | Fornieri Francesco | Board | Sell | 15,657 | 219,536.19 EUR |
2022-03-24 | Fornieri Francesco | Board | Sell | 2,818 | 39,452.00 EUR |
2022-03-23 | Fornieri Francesco | Board | Sell | 12,525 | 178,230.75 EUR |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
![]() |
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
![]() |
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
Alma Yesodot Ltd. | Israel | KVSR | ||
![]() |
Antibiotice S.A. | Romania | ATB | |
![]() |
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
![]() |
Asarina Pharma AB | Sweden | ASAP |